Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

un1Qure Genezen
Biotech

FDA grants uniQure priority review of its Huntington’s drug

Despite a tumultuous recent run with the FDA, uniQure believes an approval in May 2027 would be a “defining milestone.”
Marissa Russo Nov 2, 2026 4:12pm
Antibiotic-resistant bacteria

Biossil snags Theriva's antibiotic degraders in $91M deal

Nov 2, 2026 9:51am
The cost of waiting What reaching clinical proof-of-concept sooner means for biotech cash burn

The cost of waiting: how early proof-of-concept shapes cash burn

Brought to you by Altasciences
Teva

Teva ends trial of one of original line-up of innovative meds

Nov 2, 2026 9:22am
video
Connected clinical research from fragmentation to progress

Connected clinical research: from fragmentation to progress

Brought to you by Medrio
FDA stop sign

Bright Minds seizure study on partial hold over toxicity in mice

Nov 2, 2026 8:43am